Ardelyx News

Citi: Maintains the Ardelyx (ARDX.US) rating, adjusted from buy to buy rating, and adjusted the target price from $13.00 to $14.00.

Zhitong Finance05:50

Ardelyx Analyst Ratings

Benzinga05:47

Citigroup Maintains Buy on Ardelyx, Raises Price Target to $14

Benzinga05:49

Ardelyx Analyst Ratings

BenzingaMay 3 21:29

Wedbush Maintains Outperform on Ardelyx, Raises Price Target to $15

BenzingaMay 3 21:31

Wedbush Remains a Buy on Ardelyx (ARDX)

TipRanksMay 3 20:21

Piper Sandler Sticks to Their Buy Rating for Ardelyx (ARDX)

TipRanksMay 3 20:06

Strong Launch and Unique Product Positioning Lead to Buy Rating for Ardelyx

TipRanksMay 3 18:51

Piper Sandler Sticks to Its Buy Rating for Ardelyx (ARDX)

TipRanksApr 22 20:27

Ardelyx Analyst Ratings

BenzingaApr 18 00:52

Wedbush Maintains Outperform on Ardelyx, Raises Price Target to $14

BenzingaApr 18 00:54

Ardelyx Analyst Ratings

BenzingaApr 5 19:56

Analysts Offer Insights on Healthcare Companies: Cogent Biosciences (COGT), Lantheus (LNTH) and Ardelyx (ARDX)

TipRanksFeb 23 21:40

Ardelyx Analyst Ratings

BenzingaFeb 23 21:02

Analysts Offer Insights on Healthcare Companies: Halozyme (HALO), NeoGenomics (NEO) and Ardelyx (ARDX)

TipRanksFeb 21 21:11

Analysts' Top Healthcare Picks: Ardelyx (ARDX), Generation Bio (GBIO)

TipRanksJan 23 03:21

Wedbush Maintains Outperform on Ardelyx, Raises Price Target to $13

BenzingaJan 12 21:20

Ardelyx Analyst Ratings

BenzingaJan 12 21:19

Citigroup Raises Price Target on Ardelyx to $14 From $9, Maintains Buy Rating

MT NewswiresJan 11 00:59

Citigroup Maintains Buy on Ardelyx, Raises Price Target to $14

BenzingaJan 11 00:09